16 Results for "

quinazoline compound

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "quinazoline compound" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-13427
CAS No.: 1050500-29-2
Purity:  99.83%
Synonyms: AST-1306 (TsOH)
Target:  

EGFR

Research Areas:  

Cancer

Allitinib tosylate (AST-1306 (TsOH)) is an orally active and irreversible EGFR and ErbB2 inhibitor with IC50s of 0.5 and 3 nM, respectively. Allitinib tosylate also inhibits ErbB4 with an IC50 of 0.8 nM. Allitinib tosylate is an anilino-quinazoline compound and has anti-cancer activity
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15375
CAS No.: 897383-62-9
Purity:  99.36%
Synonyms: AST-1306; ALS 1306
Target:  

EGFR

Research Areas:  

Cancer

Allitinib (AST-1306) is an orally active and irreversible EGFR and ErbB2 inhibitor with IC50s of 0.5 and 3 nM, respectively. Allitinib also inhibits ErbB4 with an IC50 of 0.8 nM. Allitinib is an anilino-quinazoline compound and has anti-cancer activity .
loading...
    loading...
Cat. No.: HY-108419
CAS No.: 21561-09-1
Purity:  99.91%
Target:  

JNK

Research Areas:  

Cancer

WHI-P258, a quinazoline compound, binds to the active site of JAK3 with an estimated Ki of 72 µM. WHI-P258 does not inhibit JAK3 and does not affect the thrombin-induced aggregation of platelets even at 100 μM .
loading...
    loading...
Cat. No.: HY-156287
CAS No.: 796079-91-9
Purity:  ≥97.0%
Target:  

Glycosidase

Research Areas:  

Cancer

GCase modulator-1 (compound 9g), a derivative of Quinazoline, is a modulator of GCase (Glucosidase) (AC50=2.23 μM) .
loading...
    loading...
Cat. No.: HY-W014967
CAS No.: 39263-32-6
Research Areas:  

Others

5-Bromoanthranilonitrile is an organic compound that reacts with sodium hydride in dimethyl sulfoxide to produce a 4-amino-2-(2-aminophenyl)quinazoline analogue .
loading...
    loading...
Cat. No.: HY-W007977
CAS No.: 183322-18-1
Target:  

Drug Intermediate

Research Areas:  

Cancer

4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline (Compound 11 and 15) is a building block and synthetic intermediate, which can be used as a precursor in the synthesis of receptor tyrosine kinase (RTK) inhibitors, dual RTK and histone deacetylase (HDAC) inhibitors, and anticancer agents. 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline can also be used to synthesize EGFR inhibitors, including Erlotinib (HY-50896), with antiproliferative activity .
loading...
    loading...
Cat. No.: HY-163524
Target:  

Apoptosis

Research Areas:  

Cancer

NAE-IN-2 (compound III-26) is N2–(1-benzylpiperidin-4-yl)quinazoline-2,4-diamine derivative, and inhibits Cullin1 and Cullin3. NAE-IN-2 inhibits migration and induces cell apoptosis of gastric cancer cells .
loading...
    loading...
Cat. No.: HY-156020
CAS No.: 851185-20-1
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

Glucocerebrosidase-IN-2 (compound 12) is a quinazoline analogue and an inhibitor of glucocerebrosidase (GC). Glucocerebrosidase-IN-2 has the potential to improve GC translocation to lysosomes in Gaucher disease patient-derived cells (mostly carrying the N370S mutation). Glucocerebrosidase-IN-2 inhibits the hydrolysis of 4-methylumbelliferone β-D-glucopyranoside (4MU) and fluorescent glycosylceramide (FlourGC) in N370S mutant tissues with an AC50 of 25.29 μM .
loading...
    loading...
Cat. No.: HY-156149
CAS No.: 3032386-49-2
Research Areas:  

Infection

CYP51/PD-L1-IN-1 (compound L11) is a quinazoline compound with antifungal activity. CYP51/PD-L1-IN-1 is a dual inhibitor of CYP51 (IC50: 0.884 μM) and PD-L1 (IC50: 0.083 μM), which can induce early apoptosis of fungal cells in the cell cycle. CYP51/PD-L1-IN-1 also significantly reduced intracellular IL-2, NLRP3, and NF-κBp65 protein levels, induced mitochondrial damage and ROS accumulation, and ultimately led to fungal lysis and death .
loading...
    loading...
Cat. No.: HY-156150
CAS No.: 3032386-58-3
Research Areas:  

Infection

CYP51/PD-L1-IN-2 (compound L20) is a quinazoline compound with antifungal activity. CYP51/PD-L1-IN-2 is a dual inhibitor of CYP51 (IC50: 0.263 μM) and PD-L1 (IC50: 0.017 μM), which can induce early apoptosis of fungal cells in the cell cycle. CYP51/PD-L1-IN-2 also significantly reduced intracellular IL-2, NLRP3, and NF-κBp65 protein levels, induced mitochondrial damage and ROS accumulation, and ultimately led to fungal lysis and death .
loading...
    loading...
Cat. No.: HY-156151
CAS No.: 3032386-59-4
Research Areas:  

Infection

CYP51/PD-L1-IN-3 (compound L21) is a quinazoline compound with antifungal activity. CYP51/PD-L1-IN-3 is a dual inhibitor of CYP51 (IC50: 0.205 μM) and PD-L1 (IC50: 0.039 μM), which can induce early apoptosis of fungal cells in the cell cycle. CYP51/PD-L1-IN-3 also significantly reduced intracellular IL-2, NLRP3, and NF-κBp65 protein levels, induced mitochondrial damage and ROS accumulation, and ultimately led to fungal lysis and death .
loading...
    loading...
Cat. No.: HY-161512
CAS No.: 229476-71-5
Research Areas:  

Neurological Disease

hAChE/hBACE-1-IN-4 (compound AK-2) is a quinazoline derivative. hAChE/hBACE-1-IN-4 shows significant inhibitory activity against hAChE and hBACE-1 enzymes (hAChE, IC50=0.283 μM; hBACE-1, IC50=0.231 μM). hAChE/hBACE-1-IN-4 has the potential to inhibit Aβ aggregation. hAChE/hBACE-1-IN-4 has non-neurotoxicity , blood-brain barrier permeability and oral activity. hAChE/hBACE-1-IN-4 can be used in Alzheimer's disease research .
loading...
    loading...
Cat. No.: HY-175974
CAS No.: 2148927-96-0
Target:  

Parasite

Research Areas:  

Infection

Antitrypanosomal agent 27 (Compound 5c) is a quinazoline compound with antitrypanosomal activity. Antitrypanosomal agent 27 inhibits T.b. brucei with a GI50 of 31 nM. Antitrypanosomal agent 27 can be used for the research of human african trypanosomiasis .
loading...
    loading...
Cat. No.: HY-108419R
CAS No.: 21561-09-1
Target:  

Reference Standards JNK

Research Areas:  

Cancer

WHI-P258 (Standard) is the analytical standard of WHI-P258 (HY-108419). This product is intended for research and analytical applications. WHI-P258, a quinazoline compound, binds to the active site of JAK3 with an estimated Ki of 72 µM. WHI-P258 does not inhibit JAK3 and does not affect the thrombin-induced aggregation of platelets even at 100 μM .
loading...
    loading...
Cat. No.: HY-Y0823
CAS No.: 532-55-8
Research Areas:  

Infection

Benzoyl isothiocyanate is an aromatic isothiocyanate derivative with antibacterial and acaricidal activities. Benzoyl isothiocyanate inhibits the growth of specific oral bacteria, and also serves as an intermediate for the synthesis of heterocyclic compounds such as thiazolidine and quinazoline derivatives. Benzoyl isothiocyanate exhibits acaricidal activity against Dermatophagoides farina (dust mite) and D. pteronyssinus (house dust mite). Benzoyl isothiocyanate can be used in research related to bacterial infection, pest control and organic synthesis .
loading...
    loading...
Cat. No.: HY-184359
CAS No.: 2252242-31-0
Target:  

Ras

RAS GTPase-IN-2 is a RAS GTPase inhibitor. RAS GTPase-IN-2 can be used in the research of cancer, ras-related autoimmune leukocytosis and certain types of mitochondrial dysfunction .
loading...
    loading...
  • 1